Vaccitech plc American Depositary Shares (NASDAQ:VACC) Major Shareholder M&G Investment Management Ltd Purchases 125,000 Shares of Stock

Vaccitech plc American Depositary Shares (NASDAQ:VACC) major shareholder M&G Investment Management Ltd acquired 125,000 shares of the company’s stock in a transaction dated Friday, April 30th. The stock was acquired at an average price of $14.40 per share, for a total transaction of $1,800,000.00. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

VACC stock opened at $14.25 on Tuesday. Vaccitech plc American Depositary Shares has a fifty-two week low of $12.77 and a fifty-two week high of $16.26.

Vaccitech plc American Depositary Shares Company Profile

Vaccitech plc is a clinical-stage biopharmaceutical company that engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. Its therapeutic programs include VTP-300, indicated for the treatment of chronic hepatitis B infection; VTP-200, indicated for the treatment of human papilloma virus infection; VTP-850, indicated for the treatment of prostate cancer; and VTP-600, indicated for the treatment of non-small cell lung cancer.

See Also: Compound Interest and Why It Matters When Investing

Receive News & Ratings for Vaccitech plc American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaccitech plc American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.